跳至主要内容
临床试验/NCT00030680
NCT00030680已完成2 期

Phase II Pilot Study Of Moderate Dose Radiotherapy For Inoperable Aggressive Fibromatoses

European Organisation for Research and Treatment of Cancer - EORTC42 个研究点 分布在 7 个国家目标入组 44 人开始时间: 2001年11月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
44
试验地点
42
主要终点
Local control as assessed by MRI at 3 years

研究概览

简要总结

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.

PURPOSE: Phase II trial to study the effectiveness of radiation therapy in treating patients who have aggressive fibromatoses.

详细描述

OBJECTIVES:

  • Determine the efficacy of moderate-dose radiotherapy, in terms of local control, in patients with aggressive fibromatoses.
  • Determine the acute and late side-effects of this regimen in these patients.

OUTLINE: This is a multicenter study.

Patients receive radiotherapy 5 days a week for 5.5 weeks for a total of 56 Gy in 28 fractions.

Patients are followed every 3 months for 2 years and then every 6 months thereafter.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Local control as assessed by MRI at 3 years

次要结局

  • Toxicity as assessed by CTC 2.0
  • Response as assessed by MRI

研究者

申办方类型
Network
责任方
Sponsor

研究点 (42)

Loading locations...

相似试验